Related Experiment Video
Updated: Sep 27, 2025
07:59
Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
2.7K
Immunotherapy for ovarian cancer
Rebecca Porter1, Ursula A Matulonis1
1Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Clinical Advances in Hematology & Oncology : H&O
|April 7, 2022
Summary
Immune checkpoint blockade (ICB) shows limited efficacy in epithelial ovarian cancer (EOC). Novel combinations and biomarker strategies are needed to improve treatment outcomes for advanced EOC patients.
Area of Science:
- Gynecologic Oncology
- Immunotherapy
- Cancer Treatment
Background:
- Epithelial ovarian cancer (EOC) has poor survival rates, especially in advanced stages.
- Immune checkpoint blockade (ICB) showed early promise due to links between immunity and survival in EOC.
- However, single-agent ICB and current combination therapies have demonstrated low activity in EOC.
Purpose of the Study:
- To review the efficacy of ICB monotherapy and combination therapies in EOC.
- To explore novel combinations, including ICB with cellular therapies.
- To discuss potential biomarkers for patient selection in EOC immunotherapy.
Main Methods:
- Review of major clinical trial results for ICB in EOC.
- Analysis of ongoing investigations into novel ICB combinations.
- Discussion of biomarker research for predicting ICB response.
Main Results:
- Single-agent ICB has shown very low activity in epithelial ovarian cancer.
- Current combination therapies have not yet yielded robust responses in a significant proportion of EOC patients.
- Further research is exploring combinations with cellular therapies and biomarkers.
Conclusions:
- ICB monotherapy is largely ineffective in epithelial ovarian cancer.
- Developing effective combination strategies and identifying predictive biomarkers are crucial for advancing ICB in EOC treatment.
- Future research directions include novel combinations and personalized patient selection.
More Related Videos
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.4K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.8K
Related Concept Videos
01:27Tumor Immunotherapy
691
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
691
01:30Cancer Vaccines
535
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
535
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K